vimarsana.com

Latest Breaking News On - Kurt huber - Page 7 : vimarsana.com

One Month of DAPT Reasonable in Patients at High Bleeding Risk

MASTER DAPT trial included 'all-comer HBR population,' but results were with one specific stent

United statesNorth carolinaFort pierceKurt huberEd susmanE magnus ohmanCarlos aguiarEuropean association for cardioPpeuropean society of cardiologyDuke clinical research institute in durhamNew england journalHospital santa cruzCentro hospitalar lisboa ocidentalEuropean associationDuke clinical research instituteEngland journal

ERC: Barum-Rallye

Die erste Anlaufstelle im Internet für alle, die an Autos, Motorrädern und Motorsport interessiert sind!

Czech republicShimon wagnerTrawniczek jan kopeckyJan kopeckySkoda fabiaYoung ericKurt huberAndreas mikkelsenBernhard ettelEnrico windischBarum rallye ercFiaerc ercNoir trawniczek jan kopeckyKopecky paidEric would haveBehind kopecky

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

(UPDATED) The study, when coupled with FIDELIO-DKD, now opens up finerenone to diabetic patients with a wide range of CKD.

Ann arborUnited statesGerasimos filippatosKurt huberBertram pittEuropean society of cardiology congressBayer agMd sigmund freud university medical schoolMd attikon university hospitalMd university of michigan school medicineMichigan schoolHot lineEuropean societyCardiology congressNew england journalAttikon university hospital

MASTER DAPT: One Month s Enough in Patients at High Bleeding Risk

In an all-comers HBR group, 1-month DAPT was noninferior to 3 months or longer, at least with the bioresorbable stent used here.

Kurt huberUltimaster terumoMarco valgimigliPieter smitsCarlos aguiarPhd cardiocentro ticino foundationMd sigmund freud university medical schoolEuropean society of cardiologyCardiocentro ticino foundationHot lineEuropean societyNew england journalMaasstad hospitalCentro hospitalar de lisboaSigmund freud university medical school

MASTER DAPT: 1 Month DAPT Enough After High-Bleeding-Risk PCI

The study gives the first prospective randomized evidence for abbreviated dual antiplatelet therapy in this group of patients with high risk for bleeding.

New yorkUnited statesNorth carolinaDuke universityRobert byrneE magnus ohmanAstra zenecaDaiichi sankyoMichelle odonoghueRoxana mehranKurt huberMarco valgimigliDavide capodannoMount sinai school of medicineHarvard medical schoolBoston scientific

vimarsana © 2020. All Rights Reserved.